Clinical Trials Logo
  1. Home
  2. Other
  3. NCT04856878

Effect of Vancomycin After Catheter Replacement — VanCat  

Central Line-associated Bloodstream Infection (CLABSI) Clinical Trial

Official title:
Effect of Single-dose Vancomycin After Catheter Replacement for Suspected Central Line-associated Bloodstream Infection (CLABSI) on Resolution of Infection in Critically Ill Patients: A Single Center Randomized Open Label Controlled Trial

Clinical Trial Summary

Randomized controlled trial of the effect of a single-dose intravenous Vancomycin after catheter replacement for suspected central line-associated bloodstream infection on resolution of infection in critically ill patients.

Clinical Trial Description

Patients on the local intensive care unit with suspicion of central line-associated bloodstream infection will be randomized to standard of care consisting of catheter replacement and blood and catheter tip cultures and to standard of care plus a single-dose vancomycin. The effect of the intervention on resolution of humoral inflammation and negativity of blood cultures will be assessed after 48 and 96 hours. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04856878
Study type Interventional
Source University of Zurich
Contact
Status Not yet recruiting
Phase Phase 4
Start date June 1, 2021
Completion date December 31, 2024
View Details
See also
  Status Clinical Trial Phase
Withdrawn NCT03282292 - Central Venous Catheter Insertion Site and Colonization in Pediatric Cardiac Surgery N/A
Recruiting NCT05740150 - Central Line-associated Bloodstream Infection Prevention Using TauroLock-Hep100 in Pediatric Oncology Patients. N/A
Completed NCT03898115 - Implementation Program to Improve CHG Bathing Compliance N/A
Recruiting NCT04548713 - CLiCK in the Critical Care Unit N/A
Completed NCT03253887 - Ethanol-lock Therapy for the Prevention of Non-tunneled Catheter-related Infection in Pediatric Patients Phase 3
Recruiting NCT06458231 - Determining the Prevalence of Primary and Secondary Central Line Associated Blood Stream Infection (CLABSI) at the Tertiary Care Hospital
Recruiting NCT05376566 - Hydrochloric Acid Lock Therapy for Central Line-associated Bloodstream Infections N/A
Recruiting NCT01893060 - Umbilical Cord Care for the Prevention of Colonization N/A
Completed NCT00975923 - Safe Critical Care: Testing Improvement Strategies N/A
Enrolling by invitation NCT04559334 - Compassionate-Use of 4% T-EDTA Lock Solution for Central Venous Lines of Pediatric PN Patients N/A
Completed NCT05485051 - Daily Chlorexidine Bath for Health Care Associated Infection Prevention Phase 3
Completed NCT03692559 - The Effects of Different Ways of Dressing Central Line Associated Bloodstream Infections N/A
Completed NCT02969343 - Patient Safety Learning Laboratory: Making Acute Care More Patient-Centered N/A
Completed NCT03486093 - Port Protectors for Prevention of CLABSIs in Respiratory Semi-intensive Care Unit N/A
Completed NCT05919966 - The Association Between Chlorhexidine Bathing and Central Line-Associated Infections in Medical Intensive Care Units